Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2465 (LINC02465) is a long intergenic non-coding RNA (lincRNA) identified in the human genome[1]. LincRNAs are defined as non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes[3]. While the general class of lincRNAs is known to play roles in chromatin remodeling, transcriptional regulation, and possibly disease processes such as cancer, no specific biological function, disease association, or therapeutic relevance has been reported for LINC02465 in the scientific literature[1]. Therefore, it is not currently considered a therapeutic target, and there is no evidence of drugs interacting with it or of it serving as a biomarker. There are no identified safety concerns, but the absence of functional data limits its current relevance in biomedicine[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2465 (LINC02465) (LINC02465).